サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1575034

臨床試験キット市場：製品タイプ別、用途別、国別、地域別- 産業分析、市場規模、市場シェア、2024年～2032年の予測

Clinical Trial Kits Market, By Product Type, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 303 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=154.02円
臨床試験キット市場：製品タイプ別、用途別、国別、地域別- 産業分析、市場規模、市場シェア、2024年～2032年の予測
出版日: 2024年10月02日
発行: AnalystView Market Insights
ページ情報: 英文 303 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

臨床試験キット市場規模は2023年に26億4,054万米ドルとなり、2024年から2032年にかけてCAGR 9.98％で拡大しました。

また、遠隔医療やウェアラブルデバイスなどの技術の進歩が市場内のイノベーションを促進しています。分散型アプローチに対する規制当局の支援は、スポンサーが患者エンゲージメントの強化と業務の合理化を求めていることから、市場の成長をさらに後押ししています。製薬企業やバイオテクノロジー企業が患者中心の研究を優先し続ける中、臨床試験キット市場は大きく拡大する態勢を整えています。

臨床試験キット市場-市場力学

遠隔患者モニタリングと治験の分散化に対する需要の増加。

遠隔患者モニタリングの需要増加は、臨床試験キット市場の重要な促進要因です。この動向により、患者は自宅から臨床試験に参加できるようになり、エンゲージメントとコンプライアンスが強化されます。FDAの報告によると、分散型臨床試験は患者の関与を70％高め、参加者が試験プロトコルを遵守しやすくなります。

さらに、このような臨床試験は、地方や十分なサービスを受けていない人々にもアプローチすることができ、参加者は約50％増加します。このような遠隔地での方法論へのシフトは、家庭用に設計された特殊な臨床試験キットへのニーズの高まりを浮き彫りにし、最終的に市場の拡大と技術革新を促進します。

臨床試験キット市場-主な洞察

当社リサーチアナリストの分析によると、世界市場は予測期間（2024-2032年）に約9.98%のCAGRで毎年成長すると推定されます。

製品タイプ別では、輸液ポンプが2023年に最大の市場シェアを示すと予測されています。

用途別では、化学療法が2023年の主要タイプでした。

地域別では、北米が2023年の売上高でトップ

臨床試験キット市場-セグメンテーション分析：

臨床試験キットの世界市場は、製品タイプ、用途、地域に基づいてセグメント化されます。

市場は製品タイプに基づいて4つのカテゴリーに分けられる：輸液ポンプ、点滴セット、輸液カニューレ、ニードルレスコネクター。輸液ポンプは臨床試験キット市場で最も重要なセグメントです。これらの機器は、治験中に患者の安全性と治療効果を確保するため、正確な量の薬剤や輸液を供給するために不可欠です。

プログラム可能な設定やリアルタイムのモニタリングなどの高度な機能により、複雑な臨床プロトコールに不可欠なものとなっています。臨床試験が個別化医療や標的治療を含むことが多くなるにつれ、信頼性の高い輸液ポンプの需要が急増しています。この傾向は、遠隔投与とモニタリングが患者の参加とコンプライアンスに不可欠である、分散型臨床試験への傾向の高まりによってさらに裏付けられています。

市場は用途別に7つのカテゴリーに分類される：抗感染症薬、水分補給療法、化学療法、経腸栄養、非経口栄養、特殊医薬品、その他です。化学療法は臨床試験キット市場で最も重要なセグメントとして際立っています。その背景には、がん罹患率の増加と革新的な治療プロトコルのニーズの高まりがあります。

化学療法には正確なドラッグデリバリーと患者の反応を注意深くモニタリングすることが必要であり、安全性と有効性を確保するためには専用の臨床試験キットが不可欠です。さらに、標的治療や併用療法の進歩により、堅牢な化学療法関連の治験キットの需要がさらに高まっています。腫瘍学の研究が進化し続ける中、この分野は市場内で持続的な成長を遂げようとしています。

臨床試験キット市場-地理的洞察

北米の臨床試験キット市場は、強力な製薬・バイオテクノロジー部門に牽引され、堅調かつダイナミックです。デジタルヘルスソリューションやデータ分析などの技術革新への多額の投資が、臨床試験の効率性を高めています。FDAやカナダ保健省のような機関が管轄する規制状況は、企業がキットの設計やコンプライアンスに従わなければならない厳しいガイドラインを課しています。患者中心のモデルへの注目の高まりは、患者の関与と維持を向上させる家庭用キットの開発につながっています。

しかし、サプライチェーンの複雑さや物流などの課題は依然として重要です。こうしたハードルにもかかわらず、臨床試験の増加や個別化医療に対する需要の高まりに後押しされ、市場は着実に成長すると予想されます。技術革新と患者中心のアプローチを優先する企業は、この競合環境で成功を収めるのに有利な立場にあります。全体として、北米は臨床試験キット市場に大きな成長機会をもたらす活気ある市場です。

臨床試験キット市場-競合情勢：

臨床試験キット市場は、Covance、PPD、ICONのような大手医薬品開発業務受託機関（CRO）などの主要企業が牽引する多様な競合情勢が特徴です。これらの企業は、包括的なサービスを提供し、製薬会社との関係を確立しているため、この市場を独占しています。技術の進歩に伴い、リアルタイムのモニタリングのためのデジタルソリューションの統合は、臨床試験の管理方法を再構築しています。一方、患者中心のアプローチへのシフトは、家庭用キットを可能にし、リクルートとリテンションを強化しています。

バイオテクノロジー企業とCROの協力関係はイノベーションをさらに刺激し、ニッチな治療領域に特化したキットの開発を可能にしています。しかし、企業は規制遵守やサプライチェーン物流などの課題に直面しています。この進化する情勢の中で競争力を維持することを目指す企業にとって、適応能力と患者体験に焦点を当てることは極めて重要であろう。

目次

第1章 臨床試験キット市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 臨床試験キットの主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 臨床試験キット業界調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 臨床試験キット市場： COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 臨床試験キット市場情勢

  • 臨床試験キット市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 臨床試験キット市場-製品タイプ別

  • 概要
    • 製品タイプ別セグメントシェア分析
    • 輸液ポンプ
    • 点滴セット
    • IVカニューレ
    • ニードルレスコネクタ

第8章 臨床試験キット市場- 用途別

  • 概要
    • 用途別セグメントシェア分析
    • 抗感染
    • 水分補給療法
    • 化学療法
    • 経腸栄養
    • 静脈栄養
    • 特殊医薬品
    • その他

第9章 臨床試験キット市場-地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東およびアフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第10章 主要ベンダー分析- 臨床試験キット業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Thermo Fisher Scientific
    • Medpace
    • Covance（Labcorp Drug Development）
    • Parexel International
    • QuintilesIMS（IQVIA）
    • PPD（Pharmaceutical Product Development）
    • Charles River Laboratories
    • WuXi AppTec
    • BioClinica
    • Celerion
    • Syneos Health
    • Icon plc
    • Medidata Solutions
    • Veeva Systems
    • KCR
    • PRA Health Sciences
    • CROMSOURCE
    • Worldwide Clinical Trials

第11章 アナリストの全方位展望

目次
Product Code: ANV4031

REPORT HIGHLIGHT

Clinical Trial Kits Market size was valued at USD 2,640.54 million in 2023, expanding at a CAGR of 9.98% from 2024 to 2032.

The clinical trial kits market is a vital segment of the broader clinical research industry, providing essential tools and supplies for conducting trials efficiently and effectively. These kits typically include a range of components, such as diagnostic tests, drug delivery devices, and data collection tools, tailored to specific trial protocols. With the rise of decentralized clinical trials, there's an increasing demand for kits that enable remote monitoring and patient participation.

Additionally, advancements in technology, including telehealth and wearable devices, are driving innovation within the market. Regulatory support for decentralized approaches further bolsters market growth as sponsors seek to enhance patient engagement and streamline operations. As pharmaceutical and biotech companies continue to prioritize patient-centric research, the clinical trial kits market is poised for significant expansion.

Clinical Trial Kits Market- Market Dynamics

Increased demand for remote patient monitoring and decentralized trials.

The increased demand for remote patient monitoring is a significant driver in the clinical trial kits market. This trend allows patients to participate in clinical trials from home, enhancing engagement and compliance. The FDA reports that decentralized clinical trials can boost patient engagement by 70%, making it easier for participants to adhere to study protocols.

Additionally, these trials can reach rural and underserved populations, increasing participation by approximately 50%. This shift toward remote methodologies highlights the growing need for specialized clinical trial kits designed for home use, ultimately driving market expansion and innovation.

Clinical Trial Kits Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 9.98% over the forecast period (2024-2032)

Based on Product type segmentation, Infusion Pumps was predicted to show maximum market share in the year 2023

Based on Application segmentation, Chemotherapy was the leading type in 2023

based on Region, North America was the leading revenue generator in 2023

Clinical Trial Kits Market- Segmentation Analysis:

The Global Clinical Trial Kits Market is segmented based on Product Type, Application, and Region.

The market is divided into four categories based on Product type: Infusion pumps, Intravenous sets, IV cannulas, and Needleless connectors. infusion pumps are the most significant segment in the clinical trial kits market. These devices are critical for delivering precise dosages of medications and fluids, ensuring patient safety and treatment efficacy during trials.

Their advanced capabilities, such as programmable settings and real-time monitoring, make them essential for complex clinical protocols. As trials increasingly involve personalized medicine and targeted therapies, the demand for reliable infusion pumps has surged. This prominence is further supported by the growing trend towards decentralized trials, where remote administration and monitoring are crucial for patient engagement and compliance.

The market is divided into Seven categories based on Application: Anti-infective, Hydration therapy, Chemotherapy, Enteral nutrition, Parenteral nutrition, Specialty pharmaceuticals, and Others. Chemotherapy stands out as the most significant segment in the clinical trial kits market. This prominence is driven by the increasing prevalence of cancer and the growing need for innovative treatment protocols.

Chemotherapy requires precise drug delivery and careful monitoring of patient responses, making specialized clinical trial kits essential for ensuring safety and efficacy. Additionally, advancements in targeted therapies and combination treatments have further heightened the demand for robust chemotherapy-related trial kits. As research continues to evolve in oncology, this segment is poised for sustained growth within the market.

Clinical Trial Kits Market- Geographical Insights

The North American clinical trial kits market is robust and dynamic, driven by a strong pharmaceutical and biotechnology sector. Significant investments in technological innovations, such as digital health solutions and data analytics, are enhancing trial efficiency. The regulatory landscape, governed by agencies like the FDA and Health Canada, imposes stringent guidelines that companies must follow for kit design and compliance. A growing focus on patient-centric models is leading to the development of home-use kits, which improve patient engagement and retention.

However, challenges such as supply chain complexities and logistics remain critical. Despite these hurdles, the market is expected to grow steadily, fueled by an increasing number of clinical trials and a rising demand for personalized medicine. Companies prioritizing innovation and patient-centric approaches are well-positioned to thrive in this competitive environment. Overall, North America presents a vibrant landscape with significant growth opportunities in the clinical trial kits market.

Clinical Trial Kits Market- Competitive Landscape:

The clinical trial kits market is characterized by a diverse competitive landscape, driven by key players such as major contract research organizations (CROs) like Covance, PPD, and ICON. These firms dominate the space due to their comprehensive service offerings and established relationships with pharmaceutical companies. As technology advances, the integration of digital solutions for real-time monitoring is reshaping how trials are managed, while a shift toward patient-centric approaches allows for home-use kits, enhancing recruitment and retention.

Collaborative partnerships between biotech firms and CROs further stimulate innovation, enabling the development of specialized kits for niche therapeutic areas. However, companies face challenges such as regulatory compliance and supply chain logistics. Adaptability and a focus on patient experience will be crucial for companies aiming to maintain a competitive edge in this evolving landscape.

Recent Developments:

In April 2024, Baxter International Inc. announced that its Novum IQ large volume infusion pump (LVP), equipped with Dose IQ Safety Software, has received 510(k) approval from the U.S. Food and Drug Administration. This approval enables clinicians to utilize a unified, integrated system across various patient care environments.

In February 2024, Dynamic Access, LLC introduced Dynamic Infusion, a new affiliate brand that will provide home infusion nursing services for patients with chronic conditions, including autoimmune disorders, hemophilia, Crohn's disease, rheumatoid arthritis, and multiple sclerosis.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CLINICAL TRIAL KITS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Thermo Fisher Scientific
  • Medpace
  • Covance (Labcorp Drug Development)
  • Parexel International
  • QuintilesIMS (IQVIA)
  • PPD (Pharmaceutical Product Development)
  • Charles River Laboratories
  • WuXi AppTec
  • BioClinica
  • Celerion
  • Syneos Health
  • Icon plc
  • Medidata Solutions
  • Veeva Systems
  • KCR
  • PRA Health Sciences
  • CROMSOURCE
  • Worldwide Clinical Trials

GLOBAL CLINICAL TRIAL KITS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Infusion pumps
  • Intravenous sets
  • IV cannulas
  • Needleless connectors

GLOBAL CLINICAL TRIAL KITS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Anti-infective
  • Hydration therapy
  • Chemotherapy
  • Enteral nutrition
  • Parenteral nutrition
  • Specialty pharmaceuticals
  • Others

GLOBAL CLINICAL TRIAL KITS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Clinical Trial Kits Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Clinical Trial Kits Market Snippet by Product Type
    • 2.1.2. Clinical Trial Kits Market Snippet by Application
    • 2.1.3. Clinical Trial Kits Market Snippet by Country
    • 2.1.4. Clinical Trial Kits Market Snippet by Region
  • 2.2. Competitive Insights

3. Clinical Trial Kits Key Market Trends

  • 3.1. Clinical Trial Kits Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Clinical Trial Kits Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Clinical Trial Kits Market Opportunities
  • 3.4. Clinical Trial Kits Market Future Trends

4. Clinical Trial Kits Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Clinical Trial Kits Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Clinical Trial Kits Market Landscape

  • 6.1. Clinical Trial Kits Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Clinical Trial Kits Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2023 & 2032 (%)
    • 7.1.2. Infusion pumps
    • 7.1.3. Intravenous sets
    • 7.1.4. IV cannulas
    • 7.1.5. Needleless connectors

8. Clinical Trial Kits Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2. Anti-infective
    • 8.1.3. Hydration therapy
    • 8.1.4. Chemotherapy
    • 8.1.5. Enteral nutrition
    • 8.1.6. Parenteral nutrition
    • 8.1.7. Specialty pharmaceuticals
    • 8.1.8. Others

9. Clinical Trial Kits Market- By Geography

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. Clinical Trial Kits Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.2.6. U.S.
      • 9.2.6.1. Overview
      • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.6.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.2.6.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.2.7. Canada
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.7.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.2.7.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. Clinical Trial Kits Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.6. Germany
      • 9.3.6.1. Overview
      • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.6.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.6.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.7. Italy
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.7.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.7.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.8. United Kingdom
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.8.3. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.8.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.9. France
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.9.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.9.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.10. Russia
      • 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.10.2. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.10.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.11. Netherlands
      • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.11.2. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.11.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.12. Sweden
      • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.12.2. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.12.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.13. Poland
      • 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.13.2. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.13.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.14. Rest of Europe
      • 9.3.14.1. Overview
      • 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.14.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.14.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. Clinical Trial Kits Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.6. India
      • 9.4.6.1. Overview
      • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.6.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.6.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.7. China
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.7.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.7.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.8. Japan
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.8.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.8.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.9. South Korea
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.9.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.9.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.10. Australia
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.10.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.10.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.11. Thailand
      • 9.4.11.1. Overview
      • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.11.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.11.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.12. Indonesia
      • 9.4.12.1. Overview
      • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.12.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.12.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.13. Philippines
      • 9.4.13.1. Overview
      • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.13.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.13.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.14. Rest of APAC
      • 9.4.14.1. Overview
      • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.14.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.14.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. Clinical Trial Kits Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.5.4. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 9.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.6. Brazil
      • 9.5.6.1. Overview
      • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.6.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.5.6.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.7. Mexico
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.7.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.5.7.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.8. Argentina
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.8.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.5.8.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.9. Colombia
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.9.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.5.9.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.10. Rest of LATAM
      • 9.5.10.1. Overview
      • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.10.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.5.10.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. Clinical Trial Kits Key Manufacturers in Middle East and Africa
    • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 9.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.6. Saudi Arabia
      • 9.6.6.1. Overview
      • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.6.6.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.7. United Arab Emirates
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.6.7.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.8. Israel
      • 9.6.8.1. Overview
      • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.8.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.6.8.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.9. Turkey
      • 9.6.9.1. Overview
      • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.9.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.6.9.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.10. Algeria
      • 9.6.10.1. Overview
      • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.10.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.6.10.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.11. Egypt
      • 9.6.11.1. Overview
      • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.11.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.6.11.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.12. Rest of MEA
      • 9.6.12.1. Overview
      • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.12.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.6.12.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

10. Key Vendor Analysis- Clinical Trial Kits Industry

  • 10.1. Competitive Dashboard
  • 10.2. Company Profiles
    • 10.2.1. Thermo Fisher Scientific
    • 10.2.2. Medpace
    • 10.2.3. Covance (Labcorp Drug Development)
    • 10.2.4. Parexel International
    • 10.2.5. QuintilesIMS (IQVIA)
    • 10.2.6. PPD (Pharmaceutical Product Development)
    • 10.2.7. Charles River Laboratories
    • 10.2.8. WuXi AppTec
    • 10.2.9. BioClinica
    • 10.2.10. Celerion
    • 10.2.11. Syneos Health
    • 10.2.12. Icon plc
    • 10.2.13. Medidata Solutions
    • 10.2.14. Veeva Systems
    • 10.2.15. KCR
    • 10.2.16. PRA Health Sciences
    • 10.2.17. CROMSOURCE
    • 10.2.18. Worldwide Clinical Trials

11. 360 Degree Analyst View

12. Appendix

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us